Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
3R01HL034980-06S1
Application #
2217692
Study Section
Metabolism Study Section (MET)
Project Start
1986-09-01
Project End
1996-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
6
Fiscal Year
1994
Total Cost
Indirect Cost

  Institution

Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115

  Publications

Desai, Nirav K; Ooi, Esther M; Mitchell, Paul D et al. (2015) Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans. Atherosclerosis 241:326-33
Zheng, Chunyu; Khoo, Christina; Furtado, Jeremy et al. (2010) Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype. Circulation 121:1722-34
Mendivil, Carlos O; Zheng, Chunyu; Furtado, Jeremy et al. (2010) Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins. Arterioscler Thromb Vasc Biol 30:239-45
Zheng, Chunyu; Khoo, Christina; Furtado, Jeremy et al. (2008) Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that involve apolipoproteins E and C-III. Am J Clin Nutr 88:272-81
Zheng, Chunyu; Khoo, Christina; Ikewaki, Katsunori et al. (2007) Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions. J Lipid Res 48:1190-203
Campos, H; Perlov, D; Khoo, C et al. (2001) Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. J Lipid Res 42:1239-49
Tomiyasu, K; Walsh, B W; Ikewaki, K et al. (2001) Differential metabolism of human VLDL according to content of ApoE and ApoC-III. Arterioscler Thromb Vasc Biol 21:1494-500
Khoo, C; Campos, H; Judge, H et al. (1999) Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content. J Lipid Res 40:202-12
Walsh, B W; Spiegelman, D; Morrissey, M et al. (1999) Relationship between serum estradiol levels and the increases in high-density lipoprotein levels in postmenopausal women treated with oral estradiol. J Clin Endocrinol Metab 84:985-9
Su, W; Campos, H; Judge, H et al. (1998) Metabolism of Apo(a) and ApoB100 of lipoprotein(a) in women: effect of postmenopausal estrogen replacement. J Clin Endocrinol Metab 83:3267-76

Showing the most recent 10 out of 18 publications